Insider Transactions in Q2 2022 at Myovant Sciences Ltd. (MYOV)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2022
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,382
-0.53%
|
$13,820
$10.07 P/Share
|
|
Apr 19
2022
|
David C Marek Principal Executive Officer |
SELL
Open market or private sale
|
Direct |
24,594
-5.2%
|
$245,940
$10.45 P/Share
|
|
Apr 19
2022
|
Lauren Merendino Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,049
-3.87%
|
$70,490
$10.45 P/Share
|
|
Apr 19
2022
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,632
-1.75%
|
$46,320
$10.45 P/Share
|
|
Apr 19
2022
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
8,002
-2.82%
|
$80,020
$10.45 P/Share
|
|
Apr 15
2022
|
David C Marek Principal Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
134,567
+22.16%
|
-
|
|
Apr 15
2022
|
Lauren Merendino Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103,703
+36.3%
|
-
|
|
Apr 15
2022
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
111,111
+28.12%
|
-
|
|
Apr 15
2022
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103,703
+28.14%
|
-
|
|
Apr 15
2022
|
Uneek Mehra Principal Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
111,111
+34.16%
|
-
|
|
Apr 05
2022
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,922
-1.18%
|
$24,986
$13.78 P/Share
|
|
Apr 05
2022
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
2,436
-1.39%
|
$31,668
$13.78 P/Share
|